Skip to main content
Premium Trial:

Request an Annual Quote

BD Posts Q3 Revenue Decline on Negative Currency Impact

NEW YORK (GenomeWeb News) – Becton Dickinson today reported that its third-quarter 2009 revenues decreased around 2 percent, but were up approximately 5 percent excluding the negative impact of foreign currency translation.

The Franklin Lakes, NJ-based medical devices, diagnostics, and life sciences products firm generated total revenues of $1.82 billion for the three-month period ended June 30 compared to revenues of $1.85 billion for the second quarter of 2008.

Its BD Medical segment had revenues of $968.7 million, down 3 percent from $998.1 million. Its BD Diagnostics segment had revenues of $566.4 million, up 2 percent from $553.4 million.

BD Biosciences' revenue declined 4 percent to $285.2 million from $297.8 million. The firm said that excluding foreign currency impact the segment declined 1 percent. "Demand in the US for capital equipment in the research and clinical segments continued to be impacted by funding constraints," BD said in a statement.

The firm posted a profit of $341 million, or $1.39 per share, up from $297.1 million, or $1.18 per share, the year before. Its R&D expenses declined less than 2 percent to $98.5 million from $99.9 million, and its SG&A spending declined around 1 percent to $429.9 million from $435.8 million.

BD did not provide its cash position as of the end of the quarter.

Filed under

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.